Bookmark Add to Calendar

3-Hour Virtual Seminar on Handling OOS Test Results and Completing Robust Investigations

Duration : 3 Hours

Danielle DeLucy, Pharmaceuticals, Biotechnology

Danielle DeLucy, MS, is owner of ASA Training and Consulting, LLC which provides Pharmaceutical and Biologics based companies with training and quality systems assistance in order to meet Regulatory compliance. Prior to this role, Danielle has been in the industry for 15 years serving in numerous Quality Management Roles, suc Read more


This seminar will review the regulatory requirements for investigating an OOS Investigation. The responsibilities of the analyst, the supervisor and QA will be discussed. A detailed flow chart will be used to help the attendees clearly understand the steps and the order in which they are to be performed. The structure of an Investigation report which properly documents the investigation will be discussed.

The lack of or Inadequate procedures for handling out of specification (OOS) situations and failure investigations are amongst the most frequently found deviations in FDA warning letters. Most companies have procedures but either they are not adequate or are not followed. This seminar will guide attendees through the entire process from detection an out-of-specification result to informal and formal laboratory and batch investigations.

Course Objectives:

• Learn the responsibilities of analysts and supervisors
• Listen to what the FDA looks for in terms of human errors
• Describe when a full investigation should be triggered
• Describe the frequency for re-testing and re-sampling
• Learn how to implement the corrective and preventive action plans (CAPA)

Course Outline:

Session 1:

Guidelines for Detecting an OOS or Atypical Result

• Definition Atypical or Out of Specification Result?
• Review of the FDA Guidance for Industry on Investigating OOS Test Results
          o Phase I: Initial Laboratory Investigation
          o Phase II: Full Scale Investigation
• Root Cause Analysis Methods
          o 5 Whys
          o Flow Charts
          o Checklists
          o Fishbone Diagrams

Session 2:

Testing the hypotheses regarding potential root causes

• Retesting
• Considering Other Batches

Session 3:

Developing a proper CAPA plan to address any Corrective Actions

• How to properly document findings
• Example of a proper OOS investigation write up

What You Get:

• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points

Who Will Benefit:

• Quality Assurance Departments
• Quality Control Departments
• Research and Development Departments
• Regulatory Affairs Departments
• Compliance Departments
• Laboratory Staff
• Training Departments
• GMP auditors
• Consultants

Please reach us at 1-888-844-8963 for any further assistance or if you wish to register

Contact Us



Similar Trainings

Understanding Initial IND Submission- The first 30 days
LIVE : Scheduled on 17-May-2021 :01:00 PM EDT
Extractables & Leachables in Drug Development
LIVE : Scheduled on 19-May-2021 :01:00 PM EDT
3-hr Virtual Seminar: Aseptic Technique and Cleanroom Behavior – Avoiding Human Error
LIVE : Scheduled on 20-May-2021 :01:00 PM EDT
How to Prepare a Standard Operating Procedure
LIVE : Scheduled on 24-May-2021 :01:00 PM EDT
Packaging and Labeling in the Pharmaceutical Supply Chain
LIVE : Scheduled on 28-May-2021 :01:00 PM EDT
paypal payment Comodo

Copyright ©2021 GRCLEARNINC.COM. All rights reserved. | DBA Signuptraining.com